BG104286A - Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти - Google Patents

Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти

Info

Publication number
BG104286A
BG104286A BG104286A BG10428600A BG104286A BG 104286 A BG104286 A BG 104286A BG 104286 A BG104286 A BG 104286A BG 10428600 A BG10428600 A BG 10428600A BG 104286 A BG104286 A BG 104286A
Authority
BG
Bulgaria
Prior art keywords
alcohol
prevention
alcoholics
withdrawal
symptoms
Prior art date
Application number
BG104286A
Other languages
English (en)
Other versions
BG64363B1 (bg
Inventor
Aldo Fassi
Claudio Cavazza
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of BG104286A publication Critical patent/BG104286A/bg
Publication of BG64363B1 publication Critical patent/BG64363B1/bg

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/175—Amino acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Addiction (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Psychiatry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Detergent Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

Фармацевтичният състав съдържа комбинация от L-карнитин, ацетил L-карнитин и пропионил L-карнитин или фармакологично приемливи техни соли. Той може да се използва и като диетична добавка за здравословна и медицинска храна или като хранителна добавказа профилактика на пристрастяването към алкохол на здрави пациенти, по-специално млади хора.
BG104286A 1997-10-03 2000-03-30 Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти BG64363B1 (bg)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT97RM000594A IT1295408B1 (it) 1997-10-03 1997-10-03 Associazione di l-carnitina e alcanoil l-carnitine per il trattamento dell'alcoolismo

Publications (2)

Publication Number Publication Date
BG104286A true BG104286A (bg) 2000-11-30
BG64363B1 BG64363B1 (bg) 2004-12-30

Family

ID=11405277

Family Applications (1)

Application Number Title Priority Date Filing Date
BG104286A BG64363B1 (bg) 1997-10-03 2000-03-30 Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти

Country Status (28)

Country Link
US (1) US6255346B1 (bg)
EP (1) EP1022960B1 (bg)
JP (1) JP2001518484A (bg)
KR (2) KR100530368B1 (bg)
CN (1) CN1092939C (bg)
AT (1) ATE220860T1 (bg)
AU (1) AU730740B2 (bg)
BG (1) BG64363B1 (bg)
BR (1) BR9812604A (bg)
CA (1) CA2305598C (bg)
CZ (1) CZ291801B6 (bg)
DE (1) DE69806788T2 (bg)
DK (1) DK1022960T3 (bg)
EA (1) EA002177B1 (bg)
EE (1) EE04036B1 (bg)
ES (1) ES2180200T3 (bg)
HK (1) HK1028714A1 (bg)
HU (1) HUP0004336A3 (bg)
IS (1) IS2234B (bg)
IT (1) IT1295408B1 (bg)
MX (1) MXPA00003232A (bg)
NO (1) NO20001688L (bg)
NZ (1) NZ503663A (bg)
PL (1) PL189663B1 (bg)
PT (1) PT1022960E (bg)
SK (1) SK283384B6 (bg)
UA (1) UA66807C2 (bg)
WO (1) WO1999017623A1 (bg)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090848A (en) * 1997-12-01 2000-07-18 Sigma-Tau Healthscience S.P.A. Compositions and methods for increasing the concentration and/or motility of spermatozoa in humans
IT1306179B1 (it) 1999-07-28 2001-05-30 Sigma Tau Healthscience Spa Composizione per la prevenzione e cura delle disfunzioni e patologierenali di tipo tossico e funzionale.
ITRM20020194A1 (it) 2002-04-09 2003-10-09 Sigma Tau Healthscience Spa Composizione utile per aumentare la concentrazione e la motilita' degli spermatozoi e migliorarne la morfologia nell'uomo.
US7776913B2 (en) 2002-12-13 2010-08-17 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Carnitines for treating or preventing disorders caused by andropause
ITRM20020620A1 (it) * 2002-12-13 2004-06-14 Sigma Tau Ind Farmaceuti Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa.
CN101766637B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766716B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766717B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766672B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN101766715B (zh) * 2008-12-31 2012-08-29 克科 解酒醒酒组合物
CN101766635B (zh) * 2008-12-31 2012-10-10 克科 解酒醒酒组合物
CN106176756A (zh) * 2015-04-30 2016-12-07 刘力 包含手性异构化合物的赖氨酸五维药物组合物及其用途
WO2021211540A1 (en) * 2020-04-14 2021-10-21 The Regents Of The University Of California Diagnosis and treatment of addiction

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1245869B (it) * 1991-06-05 1994-10-25 Sigma Tau Ind Farmaceuti Impiego di propionil l-carnitina per il recupero del tono muscolare in soggetti immobilizzati
DE19527281A1 (de) * 1995-07-26 1997-01-30 Hans Guenter Berner Gmbh Nahrungsergänzungsmittel
DE69618749D1 (de) * 1995-12-01 2002-03-14 Unilever Nv Mikrowellen erhitzbare knusperige Brötchen
ATE187329T1 (de) * 1996-03-04 1999-12-15 Sigma Tau Ind Farmaceuti Carnitinderivat als arzneimittel zur behandlung von arteriosklerose obliterans

Also Published As

Publication number Publication date
SK4762000A3 (en) 2000-10-09
SK283384B6 (sk) 2003-06-03
PL189663B1 (pl) 2005-09-30
NO20001688L (no) 2000-06-02
KR100560097B1 (ko) 2006-03-13
JP2001518484A (ja) 2001-10-16
AU730740B2 (en) 2001-03-15
EP1022960B1 (en) 2002-07-24
DE69806788T2 (de) 2003-04-03
CN1092939C (zh) 2002-10-23
KR20050088499A (ko) 2005-09-06
ES2180200T3 (es) 2003-02-01
UA66807C2 (uk) 2004-06-15
HUP0004336A3 (en) 2001-07-30
BR9812604A (pt) 2000-08-01
IT1295408B1 (it) 1999-05-12
IS2234B (is) 2007-04-15
CN1276704A (zh) 2000-12-13
PT1022960E (pt) 2002-12-31
DE69806788D1 (de) 2002-08-29
ATE220860T1 (de) 2002-08-15
CZ20001207A3 (cs) 2000-11-15
AU9366098A (en) 1999-04-27
HK1028714A1 (en) 2001-03-02
BG64363B1 (bg) 2004-12-30
NZ503663A (en) 2001-11-30
NO20001688D0 (no) 2000-03-31
EP1022960A1 (en) 2000-08-02
IS5416A (is) 2000-03-24
CA2305598A1 (en) 1999-04-15
KR100530368B1 (ko) 2005-11-22
WO1999017623A1 (en) 1999-04-15
EE04036B1 (et) 2003-06-16
PL339621A1 (en) 2001-01-02
EA002177B1 (ru) 2002-02-28
EA200000377A1 (ru) 2000-10-30
CZ291801B6 (cs) 2003-05-14
KR20010030928A (ko) 2001-04-16
CA2305598C (en) 2007-11-20
HUP0004336A2 (hu) 2001-05-28
ITRM970594A1 (it) 1999-04-03
DK1022960T3 (da) 2002-11-04
EE200000235A (et) 2001-06-15
MXPA00003232A (es) 2004-03-10
US6255346B1 (en) 2001-07-03

Similar Documents

Publication Publication Date Title
BG104286A (bg) Състав за подтискане на симптомите при отказ и непреодолимо желание за алкохол при алкохолици и профилактика на пристрастяването към алкохол при здрави пациенти
WO1991011117A3 (en) Dietary supplements comprising vitamins and minerals
CA2341973A1 (en) Antioxidant composition comprising acetyl l-carnitine and .alpha.-lipoic acid
CA2262972A1 (en) Compositions of plant carbohydrates as dietary supplements
CA2229279A1 (en) Nutritional and/or dietary composition and method of using the same
CA2231292A1 (en) Method for decreasing ldl-cholesterol concentration and increasing hdl-cholesterol concentration in the blood to reduce the risk of atherosclerosis and vascular disease
CA2159058A1 (en) Inhibition of helicobacter
CA2271162A1 (en) Stearidonic acid compositions and uses thereof
AU1300001A (en) Gastroresistant tablets for alimentary, dietetic and therapeutic use
NZ500532A (en) Solid compositions suitable for oral administration comprising an alkanoyl-L-carnitine magnesium citrate
CA2386770A1 (en) Composition for the prevention and/or treatment of circulatory disorders, comprising derivatives of l-carnitine and extracts of ginkgo biloba
CA2288287A1 (en) Solid compositions suitable for oral administration comprising l-carnitine or alkanoyl-l-carnitine magnesium fumarate
MX9703810A (es) Medicamento que comprende un derivado de carnitinapara tratar la enfermedad de alzheimer en pacientes con inicio prematuro.
CA2395530A1 (en) Calcium formate for use as a phosphorus binder and a dietary supplement
ZA967319B (en) Preparation of pharmaceutical grade hemoglobins by heat treatment in partially oxygenated form
IL127851A0 (en) Inhibition of TNF activity
NZ500538A (en) Solid compositions suitable for oral administration comprising L-carnitine and alkanoyl-L-carnitine magnesium tartrate
TR200200224T2 (tr) Böbrek bozukluğu ve hastalıklarının önlenmesi ve tedavisi için bileşim
CA2291233A1 (en) Compositions containing bergamottin for increasing the oral bioavailability of pharmaceutical agents
CA2391625A1 (en) Composition for the prevention and/or treatment of disorders due to abnormal lipid metabolism, comprising propionyl l-carnitine and chitosan
HK1025562A1 (en) Solid compositions suitable for oral administration comprising l-carnitine choline tartrate
JP2002201135A (ja) ラクツロースを含有する上腹部用組成物
WO2001064203A3 (en) Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q¿10?